Fique off-line com o app Player FM !
The World Ahead: Year three
Série arquivada ("Feed inativo " status)
When? This feed was archived on October 13, 2022 22:11 (). Last successful fetch was on July 28, 2022 20:05 ()
Why? Feed inativo status. Nossos servidores foram incapazes de recuperar um feed de podcast válido por um período razoável.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 311321920 series 2908267
In wealthy and well-vaccinated countries, year three of the pandemic will be better than year two. But in countries that are poorer, less well vaccinated or both, the deleterious effects of the virus will linger. A disparity of outcomes between rich and poor countries will emerge. Meanwhile, tests and treatments for “long covid” are on the horizon and the mRNA technology used in some covid vaccines could be applied to other diseases. So could there be a “covid dividend”?
Host Tom Standage talks to The Economist's Edward Carr, Natasha Loder and Slavea Chankova.
For full access to print, digital and audio editions, subscribe to The Economist at www.economist.com/podcastoffer.
And we would love to hear from you—please take a moment to complete our listener survey at economist.com/worldaheadsurvey.
Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.
49 episódios
Série arquivada ("Feed inativo " status)
When? This feed was archived on October 13, 2022 22:11 (). Last successful fetch was on July 28, 2022 20:05 ()
Why? Feed inativo status. Nossos servidores foram incapazes de recuperar um feed de podcast válido por um período razoável.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 311321920 series 2908267
In wealthy and well-vaccinated countries, year three of the pandemic will be better than year two. But in countries that are poorer, less well vaccinated or both, the deleterious effects of the virus will linger. A disparity of outcomes between rich and poor countries will emerge. Meanwhile, tests and treatments for “long covid” are on the horizon and the mRNA technology used in some covid vaccines could be applied to other diseases. So could there be a “covid dividend”?
Host Tom Standage talks to The Economist's Edward Carr, Natasha Loder and Slavea Chankova.
For full access to print, digital and audio editions, subscribe to The Economist at www.economist.com/podcastoffer.
And we would love to hear from you—please take a moment to complete our listener survey at economist.com/worldaheadsurvey.
Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.
49 episódios
Todos os episódios
×Bem vindo ao Player FM!
O Player FM procura na web por podcasts de alta qualidade para você curtir agora mesmo. É o melhor app de podcast e funciona no Android, iPhone e web. Inscreva-se para sincronizar as assinaturas entre os dispositivos.